
Masterpiece (Cannabis flos Four 20 Pharma): lineage after Cap Junky and disputed profile
Masterpiece is a hybrid from Cap Junky and Platinum, which is handled by one producer in Polish pharmacies. Two sources provide different profiles for it. We describe the lineage, the declared content range, and what studies on limonene have not shown.
| Strain card | Masterpiece |
|---|---|
| Producers | Four 20 Pharma (1 pharmacy position) |
| Medical brand | the same as the producer |
| Alternative names | none |
| Category according to sources | hybrid / hybrid-indica (sources inconsistent) |
| Leading terpene | limonene |
| Other terpenes | caryophyllene linalool myrcene |
| Lineage | established Cap Junky × Platinum |
| Source consistency | divergent (2 sources) |
- Who supplies. Exclusively Four 20 Pharma, so there is nothing to compare versions with, and a supply break means no availability of this strain, not another version of it.
- Profile. Limonene leads, followed by caryophyllene, linalool, myrcene. We do not provide percentage shares because sources count them against different totals.
- Origin. The lineage is established, with parents being Cap Junky and Platinum.
- What is missing. Two sources describe the profile differently, so the rest of the set is disputed, not established.
What is Masterpiece and where does this strain come from?
Masterpiece is a hybrid developed by the American breeder In House Genetics from the cross of Cap Junky and Platinum. The lineage has been established from the seed database, so the strain belongs to that part of the catalog where parents can be named rather than just inferred from aroma similarity.
Two Polish services organizing the pharmacy catalog describe the same position differently: one records it briefly as a hybrid, the other adds an indica dominance. The difference concerns the label, not the measurement, as neither shows an analysis from which such dominance would result. We leave both versions side by side and do not choose between them.
Lineage written by intuition creates false kinships, which is why we stick to what someone has published. In the comparison, we track 85 cultivars present in the Polish pharmacy trade, and for 25 of them, no one knows the parents except the breeder. Masterpiece belongs to the opposite group: the cross is stated directly by the breeder and indexed in the seed database. Inferring from the name alone, for example, searching for relatives among positions with a similar component, leads nowhere.
This lineage record comes from the breeder’s catalog, not from genetic testing of the batch that reaches the pharmacy. Between the seed described by the breeder and the dried flower in the package stands an entire cycle of cultivation and selection, which no one publicly documents. Therefore, the lineage indicates where the name came from and what cross stands behind it, but does not confirm that each batch corresponds to this description in terms of gene.
Which producers supply Masterpiece to Polish pharmacies?
One. In the Polish pharmacy trade, the position under this name is exclusively handled by Four 20 Pharma, so there is no second version to compare it with. Four out of six strains from this producer in our comparison have no other supplier, and Masterpiece is one of them.
| Producer | Registered name without numerical component | Declared THC content as a range | How this version differs |
|---|---|---|---|
| Four 20 Pharma | Cannabis flos Four20 Pharma | 24.3-29.7% | the only version of this strain in circulation, so there is no comparison between producers |
One row is the entire answer and carries information in itself. For strains handled by several producers, it is possible to compare declarations and see where they diverge. For this position, there is nothing to compare, so every number in the table comes from one data chain.
The registered name is provided without the numerical component intentionally. The number that the producer enters into the name is a declared value and is valid with an allowable deviation of ten percent in either direction, so quoted alone suggests precision that does not exist. Hence the record 24.3-29.7% instead of a single number, and what the label itself means is explained in the text about declared potency of the dried flower.
The composition of this table is not permanent. Permits expire, wholesalers change supplies, and a producer can withdraw a single position without notice, so a strain present in the pharmacy on Tuesday may be unavailable a month later. Those checking availability should look at the current overview of available strains, not the date of this text. What else the producer handles in the catalog is described separately in the text about Four 20 Pharma.
What does this strain smell and taste like?
- caryophyllene caryophyllene
- limonene limonene (leading in the pharmacy list)
- linalool linalool
- myrcene myrcene
Catalog descriptions adhere to three terms: sour, floral, and sweet. These are records from a service organizing pharmacy assortment, not results of sensory evaluation, so they speak more about how the seller wants to set expectations than about what the patient will actually sense upon opening the package.
The leading terpene in the description of this position is limonene, the same compound responsible for the detectable note of citrus peel in orange oils. However, the scent is not evidence of composition in the other direction. The nose recognizes compounds present in trace amounts and misses those that are most abundant in the dried flower, as some of them have no scent of their own.
The taste during vaporization diverges from the smell from the package, as individual components evaporate at different temperatures, and the first draw carries a different set than the last. Therefore, the aroma description is often the least repeatable part of the strain’s characteristics: it changes with the batch, with storage conditions, and with the equipment settings.
One thing cannot be read from the aroma description, namely the strength of action. The citrus note does not predict either a milder or stronger experience, and attributing such a role to scent is a shortcut that repeats in store descriptions without measurement backing.
How long does it take for the strain to take effect and how long does the effect last?
Just like any other dried flower of a similar form, as the course is determined by the route of administration, not the strain name. After vaporization, it counts in minutes, after ingestion in hours. For Masterpiece itself, no one has measured this separately, and no publication provides such measurement.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, as pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After ingestion | |
|---|---|---|
| First sensations | after a few minutes | from half an hour to two |
| Onset | another dozen to thirty minutes | slow, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical error | none | taking a dose after thirty minutes, which gives both doses at once |
The declared THC content range, 24.3-29.7%, reaches higher than the median upper limits in this catalog, which lies around twenty-four percent. This does not shift the moment when anything begins, nor does it extend the episode. However, it changes the amount of substance taken in the same volume of vapor, which means it concerns the height of the experience, not its duration over time.
What is known and what is not known about the effects of this strain?
Not much, and not about the strain itself. No one has studied Masterpiece as a preparation, so the available evidence concerns a single aromatic component, namely limonene, and comes from studies on rodents. The rest of the description, including terms like relaxing, is catalog material, not measurement results.
The profile composition is described for this position by two sources, and they differ in how much they see in it. One lists four compounds: limonene, caryophyllene, linalool, and myrcene. The second notes only limonene. They agree on the leading component, but diverge on the rest of the profile, and we do not average this discrepancy.
We do not provide percentage shares because databases count them against different totals: sums in the same listings close at one time at forty-six percent, another time at eighty-three. Without a denominator, such a number looks like a measurement, but it is not.
| Study | Model and route of administration | What was shown |
|---|---|---|
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Limonene administered intraperitoneally in mice showed muscle relaxant effects (rota-rod test) from a dose of 50 mg/kg and prolonged sleep induced by pentobarbital at a dose of 200 mg/kg (about 2.6 times); in the elevated plus maze test, already at a dose of 5 mg/kg, it reduced the number of entries into the open arms, which the authors described as an anxiogenic effect, not anxiolytic. |
| Fakhri S et al., 2025 Behavioural Pharmacology PMID:40622197 |
rodent (rat and mouse) | Limonene reduced paw swelling induced by carrageenan in rats and pain responses in the formalin test in mice; the effect was linked to the l-arginine/nitric oxide/cGMP/KATP channel pathway and involvement of opioid and benzodiazepine receptors. |
The boundary of this data weighs as much as its result. No anxiolytic effect of limonene has been demonstrated in humans. It has also not been shown that isolated limonene acts anxiolytically in animals; the only available data from the elevated plus maze test showed in mice an effect opposite to calming, already at a low dose.
What side effects have been reported from this strain?
None, at least in a form that could be attributed to the name. The Polish supervision of pharmacotherapy safety links reports to a specific package and batch number, so there is no separate summary for Masterpiece and none will be created as long as data is collected in this way, rather than by strain name.
Reports of side effects are collected for a medicinal product with a batch number, not for the strain name, so the following concerns cannabis flower as a group of raw materials. The most commonly reported are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory, as well as anxiety increasing with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public summaries for cannabis flower in Poland do not separate them by individual products.
For this position, there is an additional circumstance visible in the data itself: the range of 24.3-29.7% lies in the upper part of the catalog, and the aforementioned anxiety has been described as increasing with dosage. This does not change the nature of the symptoms. It changes the probability with which someone will encounter them at the same volume of inhalation.
This list has one more boundary. It does not include rare events, as these only reveal themselves with a large number of reports, and public summaries for cannabis flower do not show such numbers broken down by individual positions. Therefore, the absence of an entry is not evidence that something does not exist.
What vaporizer setting suits the limonene profile?
There is no single number that could be given as correct. Limonene boils around 176 degrees Celsius, but the value on the vaporizer display describes the heater or chamber, not the dried flower itself, so two devices set the same way deliver a different set of components from the same portion.
Boiling temperature records for limonene collected in public chemical databases range between 175 and 178 degrees, depending on whether the measurement was converted from Fahrenheit and at what pressure it was performed. This discrepancy is small, but it shows how tables circulating on forums are created: different measurements of the same compound, compiled without citation.
From physics, it follows that components with a lower boiling point evaporate earlier, while heavier ones remain in the chamber for higher settings. However, it does not follow that at 176 degrees anyone gets limonene in pure form. The dried flower releases a mixture, and the proportions change with each subsequent inhalation from the same portion.
Where the differences between temperature tables come from and why the device setting is not the temperature of the dried flower, we break down in texts about evaporation of terpenes and about what the vaporizer really measures. A separate issue is dried flower available without a prescription, which is a different material than the pharmaceutical raw material described above.
Which strains are related to it?
None of those currently available in Polish pharmacies. Cap Junky and Platinum do not appear in the lineage of any other cultivar from our comparison, so the list of related strains is empty and remains empty even after checking both parents separately, not just the entire cross.
An empty list can be a correct result, not a gap in data. Siblings arise when two cultivars share an identified parent. Broad families of style, such as haze or og kush, do not create such kinship, as they are a category, not a single plant. Adding relatives by intuition would build a graph that looks rich and corresponds to nothing.
Similarity in name does not replace lineage, as seen in the same comparison: the term kush is carried by positions of completely different origins, some with established parents, some without any. Masterpiece has nothing to confuse with, as its name does not repeat in the catalog in any combination.
Instead of kinship, a composition proximity can be shown for this strain. The leading limonene is shared with sixteen of the eighty-five positions we track, and this is a completely different relationship: a common aromatic component does not mean common parents. What has been shown about limonene itself and what has not is collected in the text dedicated to this compound.
Frequently asked questions about the Masterpiece strain
Can Masterpiece be purchased in a pharmacy without a prescription?
No. Cannabis flower is issued only by a doctor’s prescription, in category Rpw, and the pharmacy fulfills the prescription for a specific registered position, not just the strain name.
How many producers supply Masterpiece to Polish pharmacies?
One. The strain under this name is exclusively handled by Four 20 Pharma in the Polish pharmacy trade, so there is no second version to compare declarations with.
What THC content does the producer declare for this strain?
The declared THC content is given as a range of 24.3-29.7%. The value on the label is valid with an allowable deviation of ten percent in either direction, so a single number from the registered name is the midpoint of the range, not the result of measuring a specific batch.
Does limonene have anxiolytic effects in humans?
This has not been demonstrated. Available studies concern rodents, and in the elevated plus maze test, isolated limonene produced an effect opposite to calming in mice, even at a low dose.
Does Masterpiece have siblings among strains available in Poland?
No. Cap Junky and Platinum do not appear in the lineage of any other cultivar from this comparison, so the list of related strains is empty, and an empty list is a result here, not a lack of data.
Why do descriptions of this strain differ between services?
Because they are based on different foundations. One service records the genetics as a hybrid, the other adds indica dominance, and only one provides the terpene composition. Neither publishes the raw result of analysis, so it cannot be resolved from the outside.
Cannabis flower is a pharmaceutical raw material issued by a doctor’s prescription in category Rpw, and this material is for informational purposes only and does not replace medical consultation. The editorial text was prepared by the ubucha editorial team.







